A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells.
about
Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human DiseaseBacterial proteins and peptides in cancer therapy: today and tomorrowThe bacterial protein azurin impairs invasion and FAK/Src signaling in P-cadherin-overexpressing breast cancer cell models.Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.p28, a first in class peptide inhibitor of cop1 binding to p53.Cell penetrating peptides can exert biological activity: a review.A nanotechnological, molecular-modeling, and immunological approach to study the interaction of the anti-tumorigenic peptide p28 with the p53 family of proteinsPeptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review.A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt.Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy.Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination.Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.Modulation of membrane properties of lung cancer cells by azurin enhances the sensitivity to EGFR-targeted therapy and decreased β1 integrin-mediated adhesion.Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.Surface Plasmon Resonance Sensing of Biorecognition Interactions within the Tumor Suppressor p53 Network.Anticancer Activity of Bacterial Proteins and Peptides.Azurin interaction with the lipid raft components ganglioside GM-1 and caveolin-1 increases membrane fluidity and sensitivity to anti-cancer drugs
P2860
Q26767093-3EAA2F25-C80C-4E65-A743-2DE9CFC10C53Q34075830-80E13756-836F-4C9A-A15B-5E8B09AFB79FQ34873875-9D42A9FE-817D-4436-8263-B327458DD2F1Q36361827-517CB2F3-9221-43D7-972C-2C5118B9E182Q36746817-F701B535-04AB-497D-B815-A2B6BFEAA1BEQ36959166-0B7C67D5-6C3D-4F1B-8656-9DFFF95EC018Q38472405-82A98CA1-8B1C-4BFC-A65F-74F90F58E8BCQ38747114-1DDF4484-A833-4765-91BE-9E01D034DB5FQ38948352-09A389A2-C9C4-40F5-86CF-993EA5753FBDQ39525778-2464AF9B-0435-4870-8C0E-1C83F931D834Q39598993-ACB92F1A-DA57-447C-89BE-AB2689F48248Q39630352-17F55B9A-6C00-48E5-8B71-1690CC488DA9Q41138860-1F445AFE-AD1F-4A92-9507-CD11870A3262Q41876620-87DD9288-17C4-43CB-B97E-FF16D3D1F701Q46299094-6BBABC29-CF8A-4965-9BC9-4C4EE5D7BBF3Q47109687-19B67EFD-A3A5-4CD0-AFA1-61E4DBAC0553Q53689854-77C4FCA4-F928-4345-B4BB-B9E2B6A6425FQ58884356-CD2F41A9-6CBE-49EC-AF16-F98CDFF2F623
P2860
A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
A peptide fragment of azurin i ...... in human breast cancer cells.
@en
A peptide fragment of azurin i ...... in human breast cancer cells.
@nl
type
label
A peptide fragment of azurin i ...... in human breast cancer cells.
@en
A peptide fragment of azurin i ...... in human breast cancer cells.
@nl
prefLabel
A peptide fragment of azurin i ...... in human breast cancer cells.
@en
A peptide fragment of azurin i ...... in human breast cancer cells.
@nl
P2093
P1476
A peptide fragment of azurin i ...... in human breast cancer cells.
@en
P2093
Albert Green
Anne Shilkaitis
Craig W Beattie
Dibyen Majumdar
Fatima Lekmine
Konstantin Christov
Laura Bratescu
Marissa L King
Rajeshwari R Mehta
Tapas K Das Gupta
P304
P356
10.1158/1535-7163.MCT-09-0444
P577
2009-10-06T00:00:00Z